Ng, Harry Ho Man https://orcid.org/0000-0001-6290-5452
Lee, Ren Yuan
Goh, Siting
Tay, Isabel Shu Ying
Lim, Xinru
Lee, Bernett
Chew, Valerie https://orcid.org/0000-0002-5617-0936
Li, Huihua
Tan, Benedict
Lim, Sherlly
Lim, Jeffrey Chun Tatt
Au, Bijin
Loh, Josh Jie Hua
Saraf, Sahil
Connolly, John Edward
Loh, Tracy
Leow, Wei Qiang
Lee, Joycelyn Jie Xin
Toh, Han Chong
Malavasi, Fabio
Lee, Ser Yee
Chow, Pierce
Newell, Evan W
Choo, Su Pin
Tai, David
Yeong, Joe
Lim, Tony Kiat Hon
Clinical trials referenced in this document:
Documents that mention this clinical trial
Achievement of cancer- and treatment-free status by atezolizumab plus bevacizumab combined with or without curative conversion in patients with transarterial chemoembolization-unsuitable, intermediate-stage hepatocellular carcinoma: A multicenter cohort study.
https://doi.org/10.1200/jco.2023.41.4_suppl.535
IMbrave150: Exploratory analysis to examine the association between bevacizumab (bev) ever being skipped and bev never being skipped in patients with unresectable hepatocellular carcinoma (HCC) treated with atezolizumab (atezo) + bev in a global phase 3 study.
https://doi.org/10.1200/jco.2023.41.4_suppl.538
Cost-effectiveness of atezolizumab plus bevacizumab versus sorafenib as first-line therapy in unresectable hepatocellular carcinoma in the US and Chinese setting: a modelling comparison study
https://doi.org/10.1136/bmjopen-2024-094804
Meta-analysis of the efficacy and safety of PD-1/PD-L1 inhibitors administered alone or in combination with anti-VEGF agents in advanced hepatocellular carcinoma
https://doi.org/10.1136/gutjnl-2019-320116
Primary and secondary pseudo-stability and progression after atezolizumab with and without bevacizumab
https://doi.org/10.1136/jitc-2025-013727
Immunohistochemical scoring of CD38 in the tumor microenvironment predicts responsiveness to anti-PD-1/PD-L1 immunotherapy in hepatocellular carcinoma
https://doi.org/10.1136/jitc-2020-000987
Immunotherapy for hepatocellular carcinoma: current status and future perspectives
https://doi.org/10.1136/esmoopen-2018-000455
Funding for this research was provided by:
National Medical Research Council (NMRC/CG/M011/2017_SGH)
National Medical Research Council (NMRC/CIRG/1454/2016)
am-ethos (AM-ETHOS01/FY2018/10-A10)